Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Damage”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT00134212
What this trial is testing

Dopexamine and Norepinephrine Compared With Epinephrine Alone in Septic Shock

Who this might be right for
Septic Shock
Rennes University Hospital 20
Early research (Phase 1)Study completedNCT03890809
What this trial is testing

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Who this might be right for
Liver DysfunctionHealthy Volunteers
Bristol-Myers Squibb 32
Not applicableLooking for participantsNCT04036357
What this trial is testing

Liver Damage and Cardiometabolic Disorders in NAFLD

Who this might be right for
NAFLDLiver FibrosesCardiovascular Diseases+1 more
University of Roma La Sapienza 2,000
Not applicableWithdrawnNCT00585429
What this trial is testing

Evaluation of Kidney Disease in Liver Transplant Recipients

Who this might be right for
Kidney DiseaseLiver Transplantation
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT02300025
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage

Who this might be right for
Healthy Volunteer
Genentech, Inc. 28
Not applicableWithdrawnNCT01923376
What this trial is testing

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)

Who this might be right for
Hepatic EncephalopathyHECirrhosis+2 more
New York Presbyterian Brooklyn Methodist Hospital
Not applicableLooking for participantsNCT06318949
What this trial is testing

Albumin Modifications as Early Biomarkers of Chronic Liver Diseases

Who this might be right for
Chronic Liver Disease
University Hospital, Limoges 756
Early research (Phase 1)Study completedNCT06952634
What this trial is testing

An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage

Who this might be right for
Hepatic Impairment
Alumis Inc 32
Large-scale testing (Phase 3)UnknownNCT00658164
What this trial is testing

Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores

Who this might be right for
Nonalcoholic Fatty Liver Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150
Not applicableStudy completedNCT01317342
What this trial is testing

Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts

Who this might be right for
Hepatocellular Injury
University of Zurich 179
Not applicableStudy completedNCT04764266
What this trial is testing

Glycocalyx During Normothermic Machine Perfusion

Who this might be right for
GlycocalyxLiver Transplantation
Medical University Innsbruck 30
Not applicableUnknownNCT03084185
What this trial is testing

Evaluation of the Role of Plasma Biomarkers in the Development of Decompensation in Patients With Cirrhosis .

Who this might be right for
Cirrhosis
University of Modena and Reggio Emilia 200
Not applicableStudy completedNCT04626570
What this trial is testing

Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity

Who this might be right for
ObesityFood Addiction
University Hospital, Tours 154
Not applicableStudy completedNCT03448679
What this trial is testing

Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT

Who this might be right for
Transplant-Related Disorder
Medical University of Vienna 50
Early research (Phase 1)Study completedNCT03679442
What this trial is testing

Macrophage Markers, Soluble CD163 (sCD163) and Soluble CD206 (sCD206) in Paracetamol Overdose

Who this might be right for
Drug-Induced Acute Liver Injury
University of Aarhus 16
Testing effectiveness (Phase 2)Study completedNCT01149304
What this trial is testing

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity

Who this might be right for
Colorectal CancerLiver MetastasesIrradiation Damage+1 more
University of Magdeburg 22
Early research (Phase 1)Looking for participantsNCT07401862
What this trial is testing

Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Who this might be right for
Hepatic Insufficiency
Eli Lilly and Company 36
Early research (Phase 1)Looking for participantsNCT06376474
What this trial is testing

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Who this might be right for
Psoriasis
Ganzhou Hemay Pharmaceutical Co., Ltd 24
Post-approval studies (Phase 4)Study completedNCT00405301
What this trial is testing

Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage

Who this might be right for
Drug Induced HepatotoxicityTuberculosis
All India Institute of Medical Sciences 175
Testing effectiveness (Phase 2)Study completedNCT00003966
What this trial is testing

Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation

Who this might be right for
Veno-occlusive Disease
Dana-Farber Cancer Institute 151
Next Page